| Literature DB >> 27298764 |
Winke Francx1, Alberto Llera2, Maarten Mennes2, Marcel P Zwiers3, Stephen V Faraone4, Jaap Oosterlaan5, Dirk Heslenfeld5, Pieter J Hoekstra6, Catharina A Hartman6, Barbara Franke7, Jan K Buitelaar8, Christian F Beckmann9.
Abstract
BACKGROUND: Magnetic resonance imaging (MRI) is able to provide detailed insights into the structural organization of the brain, e.g., by means of mapping brain anatomy and white matter microstructure. Understanding interrelations between MRI modalities, rather than mapping modalities in isolation, will contribute to unraveling the complex neural mechanisms associated with neuropsychiatric disorders as deficits detected across modalities suggest common underlying mechanisms. Here, we conduct a multimodal analysis of structural MRI modalities in the context of attention-deficit/hyperactivity disorder (ADHD).Entities:
Keywords: ADHD; Gray matter; Multimodal analysis; Structural MRI; White matter
Mesh:
Year: 2016 PMID: 27298764 PMCID: PMC4893015 DOI: 10.1016/j.nicl.2016.03.005
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographic and clinical characteristics.
| ADHD ( | Non-ADHD ( | Test statistic | |||
|---|---|---|---|---|---|
| Age, mean, SD | 17.8 | 3.2 | 17.3 | 3.5 | |
| Gender, number, % male | 90 | 69.8% | 84 | 41.2% | |
| Scan site, number, % in Nijmegen | 68 | 52.7% | 97 | 47.5% | |
| Estimated IQ | 96.9 | 15.6 | 103.0 | 13.1 | |
| History of medication use (yes/no), number, % yes | 94 | 84.7% | 15 | 8.6% | |
| Hyperactive/impulsive symptoms | 5.6 | 2.4 | 0.7 | 1.3 | |
| Inattentive symptoms | 7.3 | 1.6 | 0.9 | 1.7 | |
| Comorbid ODD, number, % | 35 | 27.1% | 5 | 2.5% | |
| Comorbid CD, number, % | 6 | 4.7% | 0 | 0% | |
ODD = oppositional defiant disorder, CD = conduct disorder.
History of stimulant medication use (based on pharmacy reports) is missing for 48 participants.
Estimated IQ based on Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale–III Vocabulary and Block Design. IQ is missing for 2 ADHD cases and 1 non-ADHD.
Symptom count according to the DSM-IV criteria (range from 0 to 9).
p < 0.01.
p < 0.001.
Fig. 1Relative weight of each modality within each component. Components are sorted first based on the modality that yielded the largest contribution, and second on their level of multimodality, i.e., how evenly distributed several modalities contributed. To quantify multimodality we calculated a multimodal index assigning a value of 1 to components to which each modality contributed equally and 0 to components to which one modality primarily contributed. The multimodal index is plotted in the bar on the left, going from 1 = white, to 0 = black. Components that yielded significant ADHD-related effects are indicated. FA = Fractional Anisotropy, MD = Mean Diffusivity, MO = Diffusion Mode, VBM = Voxel-Based Morphometry, CT = Cortical Thickness Estimate, Area = Areal Expansion Estimate.
Fig. 2Correlations between subjects' loadings on component 18 and hyperactive/impulsive and inattentive symptoms counts.
Fig. 3Multimodal component 18 related to ADHD. Spatial representation of each modality's contribution to component 18. Spatial maps were thresholded at z = 3. Blue colors indicate lower values on this MRI measure for ADHD than for control. VBM = Voxel-Based Morphometry gray matter volume, FA = Fractional Anisotropy, MD = Mean Diffusivity, MO = Diffusion Mode.
Fig. 4Correlations between subjects' loadings on component 24 and hyperactive/impulsive and inattentive symptoms counts.
Fig. 5Multimodal component 24 related to ADHD. Spatial representation of each modality's contribution to component 24. Spatial maps were thresholded at z = 3. Blue colors indicate lower values on this MRI measure for ADHD than control. VBM = Voxel-Based Morphometry gray matter volume, FA = Fractional Anisotropy, MD = Mean Diffusivity, MO = Diffusion Mode.